CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 50 enrolled
Drug / intervention
Starling SVdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05101031
NCT05101031N/ACompleted
CompareCT.gov

Evaluation of Fluid Volume in Patients With Refractory Hypotension (Fresh-ER)

Ivor Douglas·observational·Posted Oct 29, 2021·Updated Nov 21, 2023

In Brief

An observational study evaluating Starling SV for Undifferentated Shock. Completed, enrolled 50 participants across 1 site.

Detailed Summary

The objective of the study is to observe the change in hemodynamic variables (i.e. CO, SV, HR, SV) as assessed during rapid fluid bolus.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsUndifferentated Shock
CountriesUnited States
CollaboratorsOregon Health and Science University, Baxter Healthcare Corporation

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedOct 29, 2021
Enrollment StartDec 18, 2020
Primary CompletionDec 17, 2022
TodayJul 2, 2026
Enrollment to primary: 2.0 yearsPosted 4.7 years ago

Interventions

Starling SVdevice

The Starling SV will monitor the change in hemodynamic variables (i.e. CO, SV, HR, SV) as assessed during the initial fluid resuscitation in individuals with hypotension related to infection.